 Connection
Ernesto Sparrelid to Adult
This is a "connection" page, showing publications Ernesto Sparrelid has written about Adult.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.651 |
|
|
|
-
Sparrelid E, Valls-Duran C, Danielsson O, Sun W, Engstrand J, Gilg S, Ghorbani P, Sturesson C, Jansson A. Ciliated hepatic foregut cysts: a large retrospective single-centre series. Scand J Gastroenterol. 2025 Apr; 60(4):355-360.
Score: 0.049
-
Wang Q, Brismar TB, Bj?rk D, Baubeta E, Lindell G, Bj?rnsson B, Sparrelid E. Development and External Validation of a Combined Clinical-Radiomic Model for Predicting Insufficient Hypertrophy of the Future Liver Remnant following Portal Vein Embolization. Ann Surg Oncol. 2025 Mar; 32(3):1795-1807.
Score: 0.049
-
Reese T, Gilg S, B?cker J, Wagner KC, Vali M, Engstrand J, Kern A, Sturesson C, Oldhafer KJ, Sparrelid E. Impact of the future liver remnant volume before major hepatectomy. Eur J Surg Oncol. 2024 Nov; 50(11):108660.
Score: 0.048
-
Perri G, Siriwardena AK, Gilg S, Sparrelid E. European fellowship training opportunities for hepato-pancreato-biliary surgery: an international survey of fellows and program directors. HPB (Oxford). 2024 04; 26(4):503-511.
Score: 0.046
-
Villard C, Habib M, Nordenvall C, Nilsson PJ, Jorns C, Sparrelid E. Conversion therapy in patients with colorectal liver metastases. Eur J Surg Oncol. 2021 08; 47(8):2038-2045.
Score: 0.037
-
Barimani D, Kauppila JH, Sturesson C, Sparrelid E. Imaging in disappearing colorectal liver metastases and their accuracy: a systematic review. World J Surg Oncol. 2020 Oct 08; 18(1):264.
Score: 0.036
-
Bj?rnsson B, Hasselgren K, R?sok B, Larsen PN, Urdzik J, Schultz NA, Carling U, Fallentin E, Gilg S, Sandstr?m P, Lindell G, Sparrelid E. Segment 4 occlusion in portal vein embolization increase future liver remnant hypertrophy - A Scandinavian cohort study. Int J Surg. 2020 Mar; 75:60-65.
Score: 0.035
-
Sparrelid E, Johansson H, Gilg S, Nowak G, Ellis E, Isaksson B. Serial Assessment of Growth Factors Associated with Liver Regeneration in Patients Operated with Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy. Eur Surg Res. 2018; 59(1-2):72-82.
Score: 0.031
-
Sparrelid E, Jonas E, Tzortzakakis A, Dahl?n U, Murquist G, Brismar T, Axelsson R, Isaksson B. Dynamic Evaluation of Liver Volume and Function in Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy. J Gastrointest Surg. 2017 06; 21(6):967-974.
Score: 0.028
-
Sparrelid E, Gilg S, Brismar TB, Lundell L, Isaksson B. Rescue ALPPS is efficient and safe after failed portal vein occlusion in patients with colorectal liver metastases. Langenbecks Arch Surg. 2017 Feb; 402(1):69-75.
Score: 0.028
-
Bartholom? WC, Gilg S, Lundberg P, Larsen PN, Sallinen V, Sternby Eilard M, Urdzik J, Lindell G, Brismar TB, Fallentin E, Ovissi A, Socratous A, Bjerner T, Kollbeck S, Tellman J, Holmquist F, Dahlstr?m N, Woisetschl?ger M, Bj?rnsson B, Sparrelid E, Sandstr?m P. Magnetic resonance-derived hepatic uptake index improves the identification of patients at risk of severe post-hepatectomy liver failure. Br J Surg. 2025 Apr 30; 112(5).
Score: 0.013
-
Dall'Olio T, Perri G, Reese T, Sparrelid E, Gilg S. Implementation of a robotic hepato-pancreato-biliary surgery program: a swedish referral center's experience. J Robot Surg. 2025 Mar 06; 19(1):101.
Score: 0.012
-
Bonsdorff A, Kjeseth T, Kirkeg?rd J, de Ponthaud C, Ghorbani P, Wennerblom J, Williamson C, Acher AW, Thillai M, Tarvainen T, Helanter? I, Uutela A, Sir?n J, Kokkola A, Sahakyan M, Kleive D, Hagen R, Lund A, Nielsen MF, Vaillant JC, Fristedt R, Bi?rserud C, Bratlie SO, Tingstedt B, Labori KJ, Gaujoux S, Wigmore SJ, Hallet J, Sparrelid E, Sallinen V. International multicentre validation of the left pancreatectomy pancreatic fistula prediction models and development and validation of the combined DISPAIR-FRS prediction model. Br J Surg. 2025 Mar 04; 112(3).
Score: 0.012
-
Rompen IF, Stoop TF, van Roessel S, van Veldhuisen E, Janssen QP, Alseidi A, Balduzzi A, Balzano G, Berrevoet F, Bonds M, Busch OR, Butturini G, Javed AA, Del Chiaro M, Conlon KC, Falconi M, Frigerio I, Fusai GK, Gagni?re J, Griffin O, Hackert T, Sparrelid E, Halimi A, Labori KJ, Malleo G, Marino MV, Mortensen MB, Nikov A, Lesurtel M, Keck T, Kleeff J, Pand? R, Pfeiffer P, Pietrasz D, Roberts KJ, Sa Cunha A, Salvia R, Strobel O, Tarvainen T, van Laarhoven HWM, Groot Koerkamp B, Loos M, Michalski CW, Besselink MG, Hank T. Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX. Ann Surg. 2025 May 01; 281(5):852-860.
Score: 0.012
-
Oba A, Tanaka K, Inoue Y, Valente R, Rangelova E, Arnelo U, Ono Y, Sato T, Torphy RJ, Ito H, L?hr M, Takahashi Y, Schulick RD, Saiura A, Sparrelid E, Del Chiaro M. Pancreatectomies with vein resection: Two large institutions' experience of East and West. Pancreatology. 2025 Mar; 25(2):250-257.
Score: 0.012
-
Rangelova E, Stoop TF, van Ramshorst TME, Ali M, van Bodegraven EA, Javed AA, Hashimoto D, Steyerberg E, Banerjee A, Jain A, Sauvanet A, Serrablo A, Giani A, Giardino A, Zerbi A, Arshad A, Wijma AG, Coratti A, Zironda A, Socratous A, Rojas A, Halimi A, Ejaz A, Oba A, Patel BY, Bj?rnsson B, Reames BN, Tingstedt B, Goh BKP, Pay?-Llorente C, Del Pozo CD, Gonz?lez-Ab?s C, Medin C, van Eijck CHJ, de Ponthaud C, Takishita C, Schwabl C, M?nsson C, Ricci C, Thiels CA, Douchi D, Hughes DL, Kilburn D, Flanking D, Kleive D, Silva DS, Edil BH, Pando E, Moltzer E, Kauffman EF, Warren E, Bozkurt E, Sparrelid E, Thoma E, Verkolf E, Ausania F, Giannone F, H?ttner FJ, Burdio F, Souche FR, Berrevoet F, Daams F, Motoi F, Saliba G, Kazemier G, Roeyen G, Nappo G, Butturini G, Ferrari G, Kito Fusai G, Honda G, Sergeant G, Karteszi H, Takami H, Suto H, Matsumoto I, Mora-Oliver I, Frigerio I, Fabre JM, Chen J, Sham JG, Davide J, Urdzik J, de Martino J, Nielsen K, Okano K, Kamei K, Okada K, Tanaka K, Labori KJ, Goodsell KE, Alberici L, Webber L, Kirkov L, de Franco L, Miyashita M, Maglione M, Gramellini M, Ramera M, Amaral MJ, Ramaekers M, Truty MJ, van Dam MA, Stommel MWJ, Petrikowski M, Imamura M, Hayashi M, D'Hondt M, Brunner M, Hogg ME, Zhang C, Su?rez-Mu?oz M?, Luyer MD, Unno M, Mizuma M, Janot M, Sahakyan MA, Jamieson NB, Busch OR, Bilge O, Belyaev O, Franklin O, S?nchez-Vel?zquez P, Pessaux P, Holka PS, Ghorbani P, Casadei R, Sartoris R, Schulick RD, Gr?tzmann R, Sutcliffe R, Mata R, Patel RB, Takahashi R, Rodriguez Franco S, Cab?s SS, Hirano S, Gaujoux S, Festen S, Kozono S, Maithel SK, Chai SM, Yamaki S, van Laarhoven S, Mieog JSD, Murakami T, Codjia T, Sumiyoshi T, Karsten TM, Nakamura T, Sugawara T, Boggi U, Hartman V, de Meijer VE, Bartholom? W, Kwon W, Koh YX, Cho Y, Takeyama Y, Inoue Y, Nagakawa Y, Kawamoto Y, Ome Y, Soonawalla Z, Uemura K, Wolfgang CL, Jang JY, Padbury R, Satoi S, Messersmith W, Wilmink JW, Abu Hilal M, Besselink MG, Del Chiaro M. The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study. Ann Oncol. 2025 May; 36(5):529-542.
Score: 0.012
-
Radkiewicz C, Ludvigsson JF, Sparrelid E, Emilsson L. Pancreatic cancer risk after benign gallbladder disease: A Swedish population-based cohort study. Eur J Cancer. 2025 Jan; 214:115140.
Score: 0.012
-
Villard C, Widman L, Sparrelid E, Bergquist A, Hagstr?m H. The risk of cholangiocarcinoma in patients with MASLD is not increased compared to the general population. Scand J Gastroenterol. 2024 11; 59(11):1249-1251.
Score: 0.012
-
Larsson P, Swartling O, Cheraghi D, Khawaja A, Soreide K, Sparrelid E, Ghorbani P. Assessment of Outcomes by Intention-to-Treat Comparison for Locally Advanced Pancreatic Cancer: A Population-Derived Cohort Study. Ann Surg Oncol. 2025 Jan; 32(1):508-516.
Score: 0.012
-
Coppola A, La Vaccara V, Farolfi T, Asbun HJ, Boggi U, Conlon K, Edwin B, Ferrone C, Jonas E, Kokudo N, Perez EM, Satoi S, Sparrelid E, Stauffer J, Zerbi A, Takemura N, Lai Q, Almerey T, Bernon M, Cammarata R, Djoumi Y, Gallagher T, Ghorbani P, Ginesini M, Hashimoto D, Kauffmann EF, Kleive D, Llu?s N, Gonz?lez RM, Napoli N, Nappo G, Nebbia M, Ricchitelli S, Sahakyan MA, Yamamoto T, Coppola R, Caputo D. Preoperative carbohydrate antigen 19.9 level predicts lymph node metastasis in resectable adenocarcinoma of the head of the pancreas: a further plea for biological resectability criteria. Int J Surg. 2024 Oct 01; 110(10):6092-6099.
Score: 0.012
-
Kuemmerli C, Sijberden JP, Cipriani F, Osei-Bordom D, Aghayan D, Lanari J, de Meyere C, Cacciaguerra AB, Rotellar F, Fuks D, Liu R, Besselink MG, Zimmitti G, Ruzzenente A, di Benedetto F, Succandy I, Efanov M, Memeo R, Jovine E, Vrochides D, Dagher I, Croner R, Lopez-Ben S, Geller D, Ahmad J, Gallagher T, White S, Alseidi A, Goh BKP, Sparrelid E, Ratti F, Marudanayagam R, Fretland ?A, Vivarelli M, D'Hondt M, Cillo U, Edwin B, Sutcliffe RP, Aldrighetti LA, Hilal MA. Is prolonged operative time associated with postoperative complications in liver surgery? An international multicentre cohort study of 5424 patients. Surg Endosc. 2024 Dec; 38(12):7118-7130.
Score: 0.012
-
van Bodegraven EA, van Ramshorst TME, Bratlie SO, Kokkola A, Sparrelid E, Bj?rnsson B, Kleive D, Burgdorf SK, Dokmak S, Groot Koerkamp B, Cab?s SS, Molenaar IQ, Boggi U, Busch OR, Petric M, Roeyen G, Hackert T, Lips DJ, D'Hondt M, Coolsen MME, Ferrari G, Tingstedt B, Serrablo A, Gaujoux S, Ramera M, Khatkov I, Ausania F, Souche R, Festen S, Berrevoet F, Keck T, Sutcliffe RP, Pando E, de Wilde RF, Aussilhou B, Krohn PS, Edwin B, Sandstr?m P, Gilg S, Sepp?nen H, Vilhav C, Abu Hilal M, Besselink MG. Minimally invasive robot-assisted and laparoscopic distal pancreatectomy in a pan-European registry a retrospective cohort study. Int J Surg. 2024 Jun 01; 110(6):3554-3561.
Score: 0.012
-
Fr?berg K, Halimi A, Vujasinovic M, Caballero-Corbalan J, Arnelo U, Sparrelid E, Korsgren O, L?hr JM, Lundgren T, Ghorbani P. Outcome after total pancreatectomy with islet autotransplantation: A European single-center study. Scand J Surg. 2024 Jun; 113(2):80-87.
Score: 0.011
-
Larsson P, Feldt K, Holmberg M, Swartling O, Sparrelid E, Klevebro F, Ghorbani P. Preoperative heart disease and risk for postoperative complications after pancreatoduodenectomy. HPB (Oxford). 2022 11; 24(11):1854-1860.
Score: 0.010
-
Nikolic S, Ghorbani P, Pozzi Mucelli R, Ghazi S, Baldaque-Silva F, Del Chiaro M, Sparrelid E, Verbeke CS, L?hr JM, Vujasinovic M. Surgery in Autoimmune Pancreatitis. Dig Surg. 2022; 39(1):32-41.
Score: 0.010
-
Sparrelid E, H?gglund H, Remberger M, Ringd?n O, L?nnqvist B, Ljungman P, Andersson J. Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection. Bone Marrow Transplant. 1998 Oct; 22(8):795-800.
Score: 0.008
-
Sanjeevi S, Sparrelid E, Gilg S, Jonas E, Isaksson B. High incidence of biliary stricture after associating liver partition and portal vein ligation for staged hepatectomy. ANZ J Surg. 2018 Jul-Aug; 88(7-8):760-764.
Score: 0.007
-
Sparrelid E, Emanuel D, Fehniger T, Andersson U, Andersson J. Interstitial pneumonitis in bone marrow transplant recipients is associated with local production of TH2-type cytokines and lack of T cell-mediated cytotoxicity. Transplantation. 1997 Jun 27; 63(12):1782-9.
Score: 0.007
-
Sparrelid E, Ljungman P, Ekel?f-Andstr?m E, Aschan J, Ringd?n O, Winiarski J, W?hlin B, Andersson J. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplant. 1997 May; 19(9):905-8.
Score: 0.007
-
Bj?rnsson B, Sparrelid E, Hasselgren K, Gasslander T, Isaksson B, Sandstr?m P. Associating Liver Partition and Portal Vein Ligation for Primary Hepatobiliary Malignancies and Non-Colorectal Liver Metastases. Scand J Surg. 2016 Sep; 105(3):158-62.
Score: 0.007
-
Bj?rnsson B, Sparrelid E, R?sok B, Pomianowska E, Hasselgren K, Gasslander T, Bj?rnbeth BA, Isaksson B, Sandstr?m P. Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases--Intermediate oncological results. Eur J Surg Oncol. 2016 Apr; 42(4):531-7.
Score: 0.007
-
Sparrelid E, H?gglund H, Remberger M, Ljungman P, Malmborg AS, Winiarski J, Andersson J, Ringd?n O. Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation. Transplant Proc. 1995 Dec; 27(6):3530.
Score: 0.007
-
R?sok BI, Bj?rnsson B, Sparrelid E, Hasselgren K, Pomianowska E, Gasslander T, Bj?rnbeth BA, Isaksson B, Sandstr?m P. Scandinavian multicenter study on the safety and feasibility of the associating liver partition and portal vein ligation for staged hepatectomy procedure. Surgery. 2016 May; 159(5):1279-86.
Score: 0.006
-
Ringd?n O, Groth CG, Erikson A, Granqvist S, M?nsson JE, Sparrelid E. Ten years' experience of bone marrow transplantation for Gaucher disease. Transplantation. 1995 Mar 27; 59(6):864-70.
Score: 0.006
-
Blennow O, Ljungman P, Sparrelid E, Mattsson J, Remberger M. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations. Transpl Infect Dis. 2014 Feb; 16(1):106-14.
Score: 0.006
-
Omar H, H?gglund H, Gustafsson-Jernberg A, LeBlanc K, Mattsson J, Remberger M, Ringd?n O, Sparrelid E, Sundin M, Winiarski J, Yun Z, Ljungman P. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction. Transpl Infect Dis. 2009 Oct; 11(5):393-9.
Score: 0.004
-
Ljungman P, Aschan J, Lewensohn-Fuchs I, Carlens S, Larsson K, L?nnqvist B, Mattsson J, Sparrelid E, Winiarski J, Ringd?n O. Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients. Transplantation. 1998 Nov 27; 66(10):1330-4.
Score: 0.002
-
Ringd?n O, Remberger M, Carlens S, Hagglund H, Mattsson J, Aschan J, L?nnqvist B, Klaesson S, Winiarski J, Dalianis T, Olerup O, Sparrelid E, Elmhorn-Rosenborg A, Svahn BM, Ljungman P. Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies. Transplantation. 1998 Sep 15; 66(5):620-5.
Score: 0.002
-
H?gglund H, Ringd?n O, Remberger M, L?nnqvist B, Sparrelid E, Tammik L, Kumlien G. Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow. Bone Marrow Transplant. 1998 Jul; 22(2):131-6.
Score: 0.002
-
Ringd?n O, Remberger M, Mattsson J, Aschan J, Carlens S, H?gglund H, L?nnqvist B, Sparrelid E, Ljungman P. Transplantation with unrelated bone marrow in leukaemic patients above 40 years of age. Bone Marrow Transplant. 1998 Jan; 21(1):43-9.
Score: 0.002
-
Ringd?n O, Remberger M, Mattsson J, Aschan J, H?gglund H, Carlens S, L?nnqvist B, Sparrelid E, Ljungman P. Transplantation with unrelated bone marrow in leukemic patients above 40 years of age. Transplant Proc. 1997 Nov; 29(7):3145-6.
Score: 0.002
-
Andersson J, Skans?n-Saphir U, Sparrelid E, Andersson U. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages. Clin Exp Immunol. 1996 May; 104 Suppl 1:10-20.
Score: 0.002
-
Ljungman P, Johansson N, Aschan J, Glaumann H, L?nnqvist B, Ringd?n O, Sparrelid E, S?nnerborg A, Winiarski J, Gahrton G. Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients. Blood. 1995 Aug 15; 86(4):1614-8.
Score: 0.002
-
Tollemar J, Ringd?n O, Andersson S, Sundberg B, Ljungman P, Sparrelid E, Tyd?n G. Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients. Transplant Proc. 1993 Feb; 25(1 Pt 2):1495-7.
Score: 0.001
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|